http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007016008-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8125e028396d2c42a742cac34e3983bc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate | 2005-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ba9e4df41a93098cd86027717cb636 |
| publicationDate | 2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007016008-A |
| titleOfInvention | Antitumor agent |
| abstract | Disclosed is a pharmaceutical product for preventing, extinguishing / treating a tumor formed by cancer cells and the like, and a method for producing the same. A nitrilo-side compound (molecular formula C 20 H 27 NO 11 · 3H 2 0, mp 200 ° C.) and benzaldehyde by hydrolysis with enzymes Erumushin or acid (1 unit), hydrogen cyanide (1 unit), D It becomes glucose (2 units). Furthermore, when reacted with the enzyme amygdalase, it becomes prunamine and D-glucose. A complex in which dichloroacetic acid / diisoproviramine (vitamin B-15, calcium pangamate), potassium, sodium, and magnesium are added thereto is produced. By administering this, an anti-tumor effect including cancer can be exerted greatly as an immunity antibody substance. [Selection figure] None |
| priorityDate | 2005-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.